{"contentid": 488484, "importid": NaN, "name": "Grifols to build new R&D hub to work on immune disorders", "introduction": "Spanish plasma specialist Grifols is to establish a global R&D hub in Andorra, focused on the human immune system and the potential for novel immune therapies.", "content": "<p>Spanish plasma specialist Grifols (GRF: MC) is to establish a global R&amp;D hub in Andorra, focused on the human immune system and the potential for novel immune therapies.</p>\n<p>The planned facility, the Pyrenees Immunology Research Center (PYIRC), will be tasked with investigating treatments for conditions including autoimmunity disorders, cancer and emerging infectious diseases.</p>\n<p>Developed with the participation of the Andorran authorities, the center is due to be completed in 2023, and will be one of only a few in Europe dedicated to immunology.</p>\n<p>Grifols hopes the hub will attract international multidisciplinary scientists and technicians distinguished for their translational and clinical expertise.</p>\n<p>Their immunology research will also include collaborations with teams from other leading global research institutions.</p>\n<p>Grifols now has a growing research footprint, with over 1,200 people dedicated to R&amp;D at 10 centers globally.</p>\n<p>Co-chief executive V&iacute;ctor Grifols Deu said the firm was &ldquo;very pleased to build a world-class immunology R+D+i facility in Southern Europe in the green and inspirational environment of the Andorran Pyrenees.&rdquo;</p>\n<p>He added: \"The center is destined to become an international hub to advance knowledge of the immune system and develop therapeutics to enhance people&rsquo;s health and quality of life.\"</p>\n<p>Grifols will own 80% of the joint venture created to develop and manage the new center, with the remainder belonging to the Andorran government through Andorra Development and Investment, the principality&rsquo;s economic development agency.</p>", "date": "2021-04-28 14:12:00", "meta_title": NaN, "meta_keywords": "Grifols, immune, global, research, immunology, Andorra, system, center, disorders, build, work, establish, specialist, human, focused, Spanish, plasma", "meta_description": "Spanish plasma specialist Grifols is to establish a global R&D hub in Andorra, focused on the human immune system and the potential for novel immune therapies.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 1, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-28 14:12:31", "updated": "2021-04-28 16:15:08", "access": NaN, "url": "https://www.thepharmaletter.com/article/grifols-to-build-new-r-d-hub-to-work-on-immune-disorders", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "grifols-big-1.png", "image2id": "grifols-small.png", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Autoimmune Disorders, Infectious diseases, Oncology", "topic_tag": "Business Financing, Management, Research", "geography_tag": "Andorra, Spain", "company_tag": "Grifols", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-28 14:12:00"}